Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.04 USD
Change Today -0.33 / -2.15%
Volume 737.3K
BEAT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

biotelemetry inc (BEAT) Snapshot

Open
$15.64
Previous Close
$15.37
Day High
$15.88
Day Low
$15.02
52 Week High
09/2/15 - $15.89
52 Week Low
10/10/14 - $6.46
Market Cap
407.9M
Average Volume 10 Days
738.4K
EPS TTM
$0.35
Shares Outstanding
27.1M
EX-Date
--
P/E TM
42.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOTELEMETRY INC (BEAT)

Related News

No related news articles were found.

biotelemetry inc (BEAT) Related Businessweek News

No Related Businessweek News Found

biotelemetry inc (BEAT) Details

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors; and contract engineering and manufacturing services. The Research Services segment provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials to pharmaceutical companies, medical device companies, and contract research and academic research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, imaging services, and expert reporting and statistical analysis. This segment also offers support services, such as project coordination, setup and management, equipment rental, data transfer, processing, and analysis, as well as 24/7 customer support and site training. The company is headquartered in Malvern, Pennsylvania.

922 Employees
Last Reported Date: 02/23/15

biotelemetry inc (BEAT) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $535.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $338.0K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $336.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $320.0K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $310.0K
Compensation as of Fiscal Year 2014.

biotelemetry inc (BEAT) Key Developments

BioTelemetry, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

BioTelemetry, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $44.812 million compared to $42.650 million a year ago. The increase in revenue was driven by higher Patient Services revenue as a result of favorable pricing due, in part, to an increase in Medicare rates in early 2015, as well as the timing of services provided to patients. Income from operations was of $2.585 million compared to loss of $0.401 million a year ago. Income before income taxes was of $2.146 million compared to loss of $3.988 million a year ago. Net income was $2.171 million or $0.08 per diluted share compared to loss of $3.988 million or $0.15 per diluted share a year ago. Adjusted income from operations was $3.795 million compared to $0.919 million a year ago. Adjusted net income was $3.381 million or $0.12 per diluted share compared to $0.638 million or $0.02 per diluted share a year ago. Cash provided by operating activities was $7.595 million compared to $5.929 million a year ago. Capital expenditures were of $4.597 million compared to $3.751 million a year ago. Adjusted EBITDA was of $7.864 million compared to $5.126 million a year ago. EBITDA grew by 53% to $7.9 million, exceeding the expectations. For six months, the company reported revenue of $88.247 million compared to $79.812 million a year ago. Income from operations was of $3.054 million compared to loss of $4.097 million a year ago. Income before income taxes was of $2.225 million compared to loss of $10.955 million a year ago. Net income was $2.102 million or $0.07 per diluted share compared to loss of $8.110 million or $0.31 per diluted share a year ago. Adjusted income from operations was $6.124 million compared to $0.203 million a year ago. Adjusted net income was $5.172 million or $0.18 per diluted share compared to loss of $0.280 million or $0.01 per diluted share a year ago. Cash provided by operating activities was $2.989 million compared to $3.869 million a year ago. Capital expenditures were of $6.669 million compared to $7.610 million a year ago. Adjusted EBITDA was of $14.265 million compared to $8.165 million a year ago. For the third quarter of 2015, the company expects to see revenue and EBITDA increase over the second quarter of 2015 with an estimated revenue of approximately $46 million and adjusted EBITDA of around $8.4 million. This increase, as compared to the second quarter of 2015, is due to the momentum the company is seeing coming out of the first half on the top line without any increase in SG&A expense. As mentioned, the company anticipates full year EBITDA of over $32 million, representing a 6% growth year-over-year.

BioTelemetry, Inc. to Report Q2, 2015 Results on Aug 06, 2015

BioTelemetry, Inc. announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Aug 06, 2015

BioTelemetry, Inc., Q2 2015 Earnings Call, Aug 06, 2015

BioTelemetry, Inc., Q2 2015 Earnings Call, Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BEAT:US $15.04 USD -0.33

BEAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
LifeWatch AG SFr.16.35 CHF +0.15
SHL TeleMedicine Ltd SFr.10.05 CHF 0.00
View Industry Companies
 

Industry Analysis

BEAT

Industry Average

Valuation BEAT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTELEMETRY INC, please visit www.biotelinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.